GNE is trading near the bottom of its 52-week range and below its 200-day simple moving average. Price change The price of GNE shares has decreased $0.34 since the market last closed. This is a 2.37% ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
A clinical trial has led to the approval of a treatment for patients with a rare, muscle-weakening disease called GNE myopathy. In order to treat an underserved population of patients with a rare ...
Hosted on MSN
Freedom Broker upgrades Genie Energy (GNE)
Fintel reports that on May 15, 2026, Freedom Broker upgraded their outlook for Genie Energy (NYSE:GNE) from Hold to Buy. Analyst Price Forecast Suggests 22.16% Upside As of May 14, 2026, the average ...
In order to treat an underserved population of patients with a rare condition whose muscles gradually become weaker until they can no longer walk, a team of researchers across Japan have completed a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results